An observational study in Surgery, Cataract and Hip Arthroplasty, sponsored by EPI-PHARE. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2022-02-03.
Sponsored by EPI-PHARE · Observational
Determine the consequences of COVID-19 pandemic on routine targeted surgeries.
Five surgical procedures were considered : cataract surgery, hip and knee arthoplasties, coronary revascularisation by angioplasty and definitive cardiac stimulation.
The objective of the study is to quantify changes of these procedures in 2020 and in 2021 (up to June) compared to 2019 taking into account their annual evolution and according to the type of operation (primary or reoperation/revision) and emergency status, if applicable.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 2,000,000 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →This is the only study on the registry with EPI-PHARE as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All hospitalizations with at least one act of each surgery between January 1, 2019, and June 30, 2021 from the French National Health Data System (SNDS).
The National Health Data System (SNDS) is a set of strictly anonymous databases, comprising all mandatory national health insurance reimbursement data, particularly data derived from processing of health care claims (electronic or paper claims) and data from health care facilities (PMSI).
Exclusion Criteria:
-hospitalizations for personal identifier problems in the database
Procedure: surgical procedures
Procedure: surgical procedures
Procedure: surgical procedures
Procedure: surgical procedures
Procedure: surgical procedures
number of hospital stays
observed and expected number
Time frame: 2020 and first half of 2021
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.